The drug interaction databases classify this as a moderate interaction, noting that "as you lose weight during treatment with phentermine, your dosage requirement of tirzepatide or any other diabetic medications may change." This is not a minor technicality
July 2nd, 2025: Rise in Ozempic Vision Loss Lawsuits Sparks Discussion on Broadening GLP-1 MDL Scope A growing wave of lawsuits is being filed against Novo Nordisk, alleging that its GLP-1 receptor agonist medicationsincluding Ozempic and Wegovycaused permanent vision loss due to non-arteritic anterior ischemic optic neuropathy (NAION)
Regulations around peptides, including the use of CJC-1295 + Ipamorelin, vary by country, but medical consultation is strongly recommended before starting any peptide therapy
What patients typically describe is a gradual sharpening over the first 2 to 4 weeks: less brain fog, easier recall, faster processing of new information, and a sense that complex tasks feel more manageable